Foundry Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,255
| Closed | -$217K | – | 296 |
|
|
2023
Q4 | $217K | Buy |
+2,255
| New | +$217K | 0.01% | 279 |
|
|
2023
Q3 | – | Sell |
-3,188
| Closed | -$276K | – | 295 |
|
|
2023
Q2 | $276K | Hold |
3,188
| – | – | 0.02% | 293 |
|
|
2023
Q1 | $310K | Sell |
3,188
-49
| -2% | -$4.77K | 0.02% | 283 |
|
|
2022
Q4 | $335K | Buy |
3,237
+2
| +0.1% | +$207 | 0.02% | 259 |
|
|
2022
Q3 | $274K | Buy |
+3,235
| New | +$274K | 0.02% | 290 |
|
|
2022
Q1 | – | Sell |
-2,401
| Closed | -$212K | – | 336 |
|
|
2021
Q4 | $212K | Buy |
+2,401
| New | +$212K | 0.01% | 341 |
|
|
2021
Q3 | – | Sell |
-2,401
| Closed | -$200K | – | 368 |
|
|
2021
Q2 | $200K | Buy |
+2,401
| New | +$200K | 0.01% | 367 |
|
|
2021
Q1 | – | Sell |
-2,401
| Closed | -$211K | – | 435 |
|
|
2020
Q4 | $211K | Buy |
+2,401
| New | +$211K | 0.01% | 413 |
|
|
2020
Q3 | – | Sell |
-2,401
| Closed | -$296K | – | 417 |
|
|
2020
Q2 | $296K | Buy |
+2,401
| New | +$296K | 0.01% | 364 |
|
|
2017
Q2 | – | Sell |
-3,158
| Closed | -$277K | – | 414 |
|
|
2017
Q1 | $277K | Sell |
3,158
-84
| -3% | -$7.37K | 0.01% | 413 |
|
|
2016
Q4 | $269K | Buy |
+3,242
| New | +$269K | 0.01% | 418 |
|